2026 NPPES data Pediatric Endocrinology Physician NPI 1174555957 M.D.
Verify on CMS →

LARRY MIDYETT, M.D.

Pediatric Endocrinology Physician in OVERLAND PARK, Kansas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 170 beneficiaries · Pediatric Endocrinology Physician avg: 151
Generic prescribing
45%
generic claims · 55% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$33.6K
92 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: LARRY MIDYETT, M.D. is a Pediatric Endocrinology Physician ([object Object]) practicing in OVERLAND PARK, Kansas with a Medicare Part D prescribing footprint of 2K claims across 170 beneficiaries — 55% brand-name prescribing . Industry payments of $33.6K across 92 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: LARRY MIDYETT, M.D. filed 1,541 Medicare Part D claims in 2023 across OVERLAND PARK, Kansas. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

LARRY MIDYETT, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

LARRY MIDYETT, M.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 07/06/2006

NPI 1174555957

Primary specialty

Pediatric Endocrinology Physician

Niche

1,457 US NPIs in this specialty

Medicare Part D claims

1,541 921% vs specialty avg

2023 prescription claims

Specialty avg: 151

Specialty distribution in Kansas

How Pediatric Endocrinology Physician compares to other specialties among Kansas providers

Kansas providers

Pediatric Endocrinology Physician share within Kansas

1. Pediatric Endocrinology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pediatric Endocrinology Physician share within Kansas

Specialty board-certification context

Estimated specialty board-certified rate — Pediatric Endocrinology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pediatric Endocrinology Physician ABMS/AOA estimate

Est. board-certified rate (Pediatric Endocrinology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pediatric Endocrinology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

LARRY MIDYETT, M.D. is a Pediatric Endocrinology Physician provider practicing in OVERLAND PARK, Kansas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1174555957. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

LARRY MIDYETT, M.D. appears in the CMS NPPES registry as a Pediatric Endocrinology Physician provider holding M.D. credentials at 12330 METCALF AVE, OVERLAND PARK, KS, 66213, with a listed phone of (913) 317-3170. NPI 1174555957 was issued on 07/06/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MIDYETT most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,541 prescription claims written by this provider, covering 170 Medicare beneficiaries and totaling roughly $1.1 million in drug spend, split 55% brand-name and 45% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pediatric Endocrinology Physician is a narrow specialty nationwide, with 1,457 enrolled providers across 51 states and an average of 151 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

12330 METCALF AVE
OVERLAND PARK, KS 66213

Provider Details

NPI 1174555957
Specialty Pediatric Endocrinology Physician
Credentials M.D.
Gender Male
NPI Issued 07/06/2006

Hospital and facility affiliations

Facilities where LARRY MIDYETT, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

SAINT LUKES PHYSICIAN GROUP INC
KANSAS CITY, MO

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for LARRY MIDYETT, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$33.6K

Largest payer

Abbott Laboratories

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Brand-heavy

LARRY MIDYETT, M.D. — brand share 55.0%
Specialty average (est.)

55% brand-name claims vs 45% generic, on 1,541 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,541
Total Claims
$1.1M
Total Drug Cost
170
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
3,160
Total Day Supply
92,995
Brand vs Generic
55% brand / 45% generic
Brand Drug Cost
$963K
Generic Drug Cost
$33K

Patient Demographics

Average Patient Age
64.8 years
Avg HCC Risk Score
1.51
Gender Split
65% female / 35% male
Age Distribution
<65: 59, 65-74: 78, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Levothyroxine Sodium
161
Ozempic
Semaglutide
92
Trulicity
Dulaglutide
71
Jardiance
Empagliflozin
54
Mounjaro
Tirzepatide
45
Metformin Hcl
42
Glimepiride
38
Novolog Flexpen
Insulin Aspart
30
Novolog
Insulin Aspart
28
Insulin Lispro Kwikpen U-100
Insulin Lispro
24

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pediatric Endocrinology Physician Overview

How LARRY MIDYETT, M.D. fits within the Pediatric Endocrinology Physician landscape nationally.

1,457
Pediatric Endocrinology Physician Providers in US
51
States with Pediatric Endocrinology Physician
151
Avg Claims per Provider

LARRY MIDYETT, M.D.'s 1,541 claims are above the specialty average of 151.

Nearby Pediatric Endocrinology Physician Providers in Kansas

Other clinicians with the same primary specialty enrolled in Kansas, drawn from the same CMS NPPES roster as MIDYETT.

Compare Pediatric Endocrinology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is LARRY MIDYETT, M.D.'s specialty?
LARRY MIDYETT, M.D. specializes in Pediatric Endocrinology Physician and practices in OVERLAND PARK, Kansas. Credentials: M.D..
How much does LARRY MIDYETT, M.D. prescribe under Medicare Part D?
In 2023, LARRY MIDYETT, M.D. wrote 1,541 Medicare Part D claims totaling $1.1M in drug costs for 170 beneficiaries.
Where is LARRY MIDYETT, M.D. located?
LARRY MIDYETT, M.D. is located at 12330 METCALF AVE, OVERLAND PARK, KS, 66213. Phone: (913) 317-3170.
What is LARRY MIDYETT, M.D.'s NPI number?
LARRY MIDYETT, M.D.'s National Provider Identifier (NPI) is 1174555957, issued on 07/06/2006.
Does LARRY MIDYETT, M.D. prescribe more brand-name or generic drugs?
LARRY MIDYETT, M.D.'s prescribing is 55% brand-name and 45% generic drugs by claim count, with $963K in brand drug costs.
How many Pediatric Endocrinology Physician providers are there in the US?
There are 1,457 Pediatric Endocrinology Physician providers across 51 states in the US. The average Pediatric Endocrinology Physician provider writes 151 Medicare Part D claims per year.
What drugs does LARRY MIDYETT, M.D. prescribe most often?
Based on 2023 Medicare Part D data, LARRY MIDYETT, M.D.'s most frequently prescribed drugs include Levothyroxine Sodium, Ozempic, Trulicity. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does LARRY MIDYETT, M.D. accept Medicare?
LARRY MIDYETT, M.D. appears in CMS Medicare data with 1,541 Part D claims and 170 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify LARRY MIDYETT, M.D.'s credentials?
LARRY MIDYETT, M.D.'s NPI is 1174555957 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology